NM_000059.4(BRCA2):c.2671G>C (p.Val891Leu) AND Cancer of the pancreas

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 16, 2017
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000677822.2

Allele description [Variation Report for NM_000059.4(BRCA2):c.2671G>C (p.Val891Leu)]

NM_000059.4(BRCA2):c.2671G>C (p.Val891Leu)

Gene:

BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

13q13.1

Genomic location:

Preferred name:

NM_000059.4(BRCA2):c.2671G>C (p.Val891Leu)

HGVS:

NC_000013.11:g.32337026G>C
NG_012772.3:g.26547G>C
NM_000059.4:c.2671G>CMANE SELECT
NP_000050.2:p.Val891Leu
NP_000050.3:p.Val891Leu
LRG_293t1:c.2671G>C
LRG_293:g.26547G>C
LRG_293p1:p.Val891Leu
NC_000013.10:g.32911163G>C
NM_000059.3:c.2671G>C

Protein change:

V891L

Links:

dbSNP: rs756951335

NCBI 1000 Genomes Browser:

rs756951335

Molecular consequence:

NM_000059.4:c.2671G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Cancer of the pancreas
Synonyms:: Pancreatic cancer
Identifiers:: MedGen: C0346647

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000803982	3DMed Clinical Laboratory Inc	no assertion criteria provided (ACMG Guidelines, 2015)	Uncertain significance (Jan 16, 2017)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000803982

3DMed Clinical Laboratory Inc

no assertion criteria provided

(ACMG Guidelines, 2015)

Uncertain significance
(Jan 16, 2017)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From 3DMed Clinical Laboratory Inc, SCV000803982.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine